Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GlaxoSmithKline's OTC Garage Sale Includes alli, FiberChoice

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline includes the alli weight-loss brand in its planned divestment of international OTCs worth about $813 million in 2010 sales, or 10% of the firm's total Consumer Healthcare business.
Advertisement

Related Content

Insight Acquires Monistat In Third Deal With McNeil For Women’s OTC Drugs
Education About NRT Safety Overcomes Smokers’ Cost Barrier – Study
GSK Urges Regulatory Changes To Pull EU Market From Doldrums
Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
In Brief
In Brief
Sales & Earnings In Brief
Sales & Earnings In Brief
Freed From Pfizer, Capsugel May Find More Market Opportunities
Obesity Drug Developers Aim To Navigate Regulatory Backroads

Topics

Advertisement
UsernamePublicRestriction

Register

PS104990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel